Yaoren Hu

1.8k total citations
51 papers, 1.3k citations indexed

About

Yaoren Hu is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Yaoren Hu has authored 51 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Epidemiology and 14 papers in Hepatology. Recurrent topics in Yaoren Hu's work include Hepatitis B Virus Studies (10 papers), Liver Disease Diagnosis and Treatment (10 papers) and MicroRNA in disease regulation (8 papers). Yaoren Hu is often cited by papers focused on Hepatitis B Virus Studies (10 papers), Liver Disease Diagnosis and Treatment (10 papers) and MicroRNA in disease regulation (8 papers). Yaoren Hu collaborates with scholars based in China, United Kingdom and Panama. Yaoren Hu's co-authors include Liyun Fu, Junming Guo, Qingqing Chen, Ting Yao, Airong Hu, Tianwen Li, Huadong Yan, Shun Zhang, Xiaoyan Mo and Yu Shi and has published in prestigious journals such as Hepatology, Biochemical and Biophysical Research Communications and Journal of Hepatology.

In The Last Decade

Yaoren Hu

51 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaoren Hu China 20 695 526 399 343 158 51 1.3k
Qinghua Meng China 19 334 0.5× 252 0.5× 734 1.8× 605 1.8× 100 0.6× 70 1.4k
Hikmet Akkız Türkiye 23 505 0.7× 340 0.6× 443 1.1× 305 0.9× 30 0.2× 73 1.4k
Jinhua Hu China 20 349 0.5× 190 0.4× 400 1.0× 467 1.4× 101 0.6× 99 1.2k
Chuantao Tu China 24 425 0.6× 195 0.4× 579 1.5× 453 1.3× 210 1.3× 38 1.4k
Hyuk Soo Eun South Korea 20 460 0.7× 215 0.4× 420 1.1× 278 0.8× 72 0.5× 68 1.3k
Bicheng Chen China 21 615 0.9× 507 1.0× 277 0.7× 162 0.5× 46 0.3× 42 1.2k
Émilie Crouchet France 10 296 0.4× 137 0.3× 727 1.8× 710 2.1× 92 0.6× 17 1.2k
Myoung-Kuk Jang South Korea 9 708 1.0× 154 0.3× 454 1.1× 245 0.7× 26 0.2× 14 1.2k
Ali Mencin United States 10 641 0.9× 131 0.2× 687 1.7× 317 0.9× 31 0.2× 22 1.4k
Sherilyn Gordon Burroughs United States 7 365 0.5× 214 0.4× 264 0.7× 369 1.1× 29 0.2× 9 1.0k

Countries citing papers authored by Yaoren Hu

Since Specialization
Citations

This map shows the geographic impact of Yaoren Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaoren Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaoren Hu more than expected).

Fields of papers citing papers by Yaoren Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaoren Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaoren Hu. The network helps show where Yaoren Hu may publish in the future.

Co-authorship network of co-authors of Yaoren Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Yaoren Hu. A scholar is included among the top collaborators of Yaoren Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaoren Hu. Yaoren Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Jin, Tianyu Zhu, Peng Song, et al.. (2024). Surface-Engineered Polygonatum Sibiricum Polysaccharide CaCO3 Microparticles as Novel Vaccine Adjuvants to Enhance Immune Response. Molecular Pharmaceutics. 21(8). 3936–3950. 7 indexed citations
2.
Yu, Ruihong, Lan Jin, Huina Liu, et al.. (2024). Polyethyleneimine-modified Laminarin nanoparticles as a novel vaccine adjuvant for ovalbumin to enhance the immune responses. International Journal of Biological Macromolecules. 292. 139157–139157. 4 indexed citations
3.
Hu, Meng‐Yuan, Xue Li, Qing Xia, et al.. (2023). Exosomes and circular RNAs: promising partners in hepatocellular carcinoma from bench to bedside. Discover Oncology. 14(1). 60–60. 6 indexed citations
4.
Hu, Yaoren, et al.. (2021). Interleukin-28B Polymorphisms Predict the Efficacy of Peginterferon Alpha in Patients With Chronic Hepatitis B: A Meta-Analysis. Frontiers in Medicine. 8. 691365–691365. 6 indexed citations
5.
Fu, Liyun, Shuwei Wang, Meng‐Yuan Hu, et al.. (2020). Circular RNAs in liver diseases: Mechanisms and therapeutic targets. Life Sciences. 264. 118707–118707. 18 indexed citations
6.
Zhu, Hui, Liyun Fu, Shun Zhang, et al.. (2020). Clinical features of COVID‐19 convalescent patients with re‐positive nucleic acid detection. Journal of Clinical Laboratory Analysis. 34(7). e23392–e23392. 48 indexed citations
7.
Wang, Shuwei, et al.. (2020). CHI3L1 in the pathophysiology and diagnosis of liver diseases. Biomedicine & Pharmacotherapy. 131. 110680–110680. 31 indexed citations
8.
Chen, Xinyue, Xiaoguang Dou, Qing Xie, et al.. (2019). A Potential Functional Cure in Chinese HBeAg-negative Chronic Hepatitis B Patients Treated with Peg-interferon Alpha-2a. Journal of Clinical and Translational Hepatology. 7(X). 1–9. 6 indexed citations
9.
Liang, Lili, et al.. (2019). PS-098-Prevalence and risk factors of first line anti-tuberculosis drug induced liver injury: Large cohort study involving 4652 patients. Journal of Hepatology. 70(1). e62–e63. 2 indexed citations
10.
Tan, Jun, et al.. (2017). Antibiotic tigecycline enhances cisplatin activity against human hepatocellular carcinoma through inducing mitochondrial dysfunction and oxidative damage. Biochemical and Biophysical Research Communications. 483(1). 17–23. 63 indexed citations
11.
Shi, Yu, Huadong Yan, Hong Fang, et al.. (2015). The Clinical Course of Cirrhosis Patients Hospitalized for Acute Hepatic Deterioration. Medicine. 94(47). e2031–e2031. 9 indexed citations
12.
Chen, Si, Yi Chen, Bi Chen, et al.. (2015). Plumbagin Ameliorates CCl4-Induced Hepatic Fibrosis in Rats via the Epidermal Growth Factor Receptor Signaling Pathway. Evidence-based Complementary and Alternative Medicine. 2015. 1–12. 19 indexed citations
13.
Hu, Airong, et al.. (2015). DNA repair gene XRCC3 T241M polymorphism and susceptibility to hepatocellular carcinoma in a Chinese population: a meta-analysis. Genetics and Molecular Research. 14(4). 15988–15996. 9 indexed citations
14.
Zhou, Jun, et al.. (2014). Cryptotanshinone Induces Inhibition of Breast Tumor Growth by Cytotoxic CD4+ T Cells through the JAK2/STAT4/ Perforin Pathway. Asian Pacific Journal of Cancer Prevention. 15(6). 2439–2445. 26 indexed citations
16.
Hu, Airong, et al.. (2013). Anti-hepatoma cells function of luteolin through inducing apoptosis and cell cycle arrest. Tumor Biology. 35(4). 3053–3060. 45 indexed citations
17.
Hu, Yaoren, et al.. (2012). An improved reverse dot hybridization for simple and rapid detection of adefovir dipivoxil-resistant hepatitis B virus. Genetics and Molecular Research. 11(1). 53–60. 2 indexed citations
19.
Guo, Junming, Yao Feng, Bingxiu Xiao, et al.. (2007). Detecting Carcinoma Cells in Peripheral Blood of Patients With Hepatocellular Carcinoma by Immunomagnetic Beads and RT-PCR. Journal of Clinical Gastroenterology. 41(8). 783–788. 26 indexed citations
20.
Feng, Yao, Junming Guo, Bingxiu Xiao, et al.. (2005). Detecting AFP mRNA in peripheral blood of the patients with hepatocellular carcinoma, liver cirrhosis and hepatitis. Clinica Chimica Acta. 361(1-2). 119–127. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026